Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorhexidine + metronidazole is a combination medication primarily used for treating oral and gum infections. This combination leverages the antiseptic properties of chlorhexidine gluconate and the antibiotic action of metronidazole to effectively combat bacterial infections in the mouth. ## Mechanism of Action This combination works through dual mechanisms: 1. **Chlorhexidine Gluconate**: Acts as an antiseptic and disinfectant by binding to the surface of teeth, inner cheeks, and gums. This kills infectious microorganisms that cause gum disease, tartar, and other mouth infections[1][3]. 2. **Metronidazole**: Functions as an antibiotic that kills bacteria and other infectious microorganisms by damaging their DNA[1][3]. ## Uses The primary uses of chlorhexidine + metronidazole include: - Treatment of mouth infections and associated symptoms like ulcers and swelling[1] - Management of gingivitis and periodontitis[2][6] - Control of dental plaque and tartar[6] - Treatment of bad breath (halitosis)[6] - Post-dental surgery infection prevention[6] - Oral ulcer and sore treatment[6] ## Available Formulations This combination is available in various forms including: - Oral gels - Mouthwashes - Dental treatments ## Brand Names Several pharmaceutical companies manufacture this combination under different brand names including: - Septacare-M - Metzine - Hygina - Fogum - Orahex M - Dentonex M - Metrohex - Orex M - Metrolite DG - Metroross DG Forte[1] ## Side Effects Common side effects of chlorhexidine + metronidazole include: - Bitter taste - Staining of teeth and tongue - Altered taste sensation - Oral irritation - Dryness in the mouth - Nausea and vomiting[1][3] ## Clinical Evidence Research has shown that the combination of chlorhexidine and metronidazole can be effective in treating gingivitis. Studies have demonstrated significant improvements based on microbiological and clinical assessments, which has reduced the need for surgical treatments of gingiva and supporting structures[2]. Recent reports indicate that combining silver nanoparticles with chlorhexidine and metronidazole produces excellent bacteriostatic and bactericidal effects, showing promising results for future treatment approaches[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chlorhexidine + metronidazole.